Maravai LifeSciences Holdings, Inc.MRVINASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank0
3Y CAGR-34.0%
5Y CAGR-13.8%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-34.0%/yr
vs +32.3%/yr prior
5Y CAGR
-13.8%/yr
Recent deceleration
Acceleration
-66.3pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$40.13M-88.3%
2024$343.93M+100.1%
2023$171.85M+22.9%
2022$139.83M+34.4%
2021$104.03M+23.0%
2020$84.55M+61.6%
2019$52.30M+14.5%
2018$45.69M-